4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001193125-25-325007
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SKYLER JAY S Director | 2025-12-16 | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…